Companion Animal Postoperative Pain Management Therapeutics Market to Expand at A CAGR of 6.5%by 2032

Market Overview: The global market for therapeutics addressing postoperative pain in companion animals attained a value of USD 681.81 million in 2022 and is poised to achieve USD 1.20 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.5% throughout the forecast period. Key drivers propelling revenue expansion include the escalating adoption of companion animals, increased prevalence of surgical procedures among these animals, and heightened awareness among pet owners regarding the significance of pain management in animals.

The surge in companion animal adoption worldwide stands out as a pivotal factor fueling the revenue growth of the companion animal postoperative pain management therapeutics market. Notably, the adoption of pets like dogs, cats, and horses has surged, leading to a notable uptick in surgical interventions for these animals and subsequently, a heightened demand for postoperative pain management therapeutics.

Get a sample copy of the Companion Animal Postoperative Pain Management Therapeutics Market report: https://www.reportsanddata.com/download-free-sample/6341

Moreover, there is a discernible shift among pet owners towards recognizing the importance of postoperative pain management in their pets, thereby further stimulating market revenue growth. According to the American Veterinary Medical Association (AVMA), effective pain management is considered integral to veterinary care, especially during the postoperative phase for companion animals.

Technological advancements in postoperative pain management therapeutics are also expected to drive market growth, with the development of novel drugs and innovative delivery mechanisms such as transdermal patches and injectables enhancing the demand for companion animal postoperative pain management therapeutics.

However, the high cost associated with postoperative pain management therapeutics for companion animals presents a notable restraint to market growth, particularly in developing economies where affordability remains a challenge.

Key Insights: Product Categories: The global market for companion animal postoperative pain management therapeutics is segmented by product type, including Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), opioids, local anesthetics, and others. NSAIDs, renowned for their analgesic and anti-inflammatory properties, dominated the market in 2022 owing to their effectiveness in pain relief and inflammation reduction.

The opioids segment is anticipated to witness the fastest revenue CAGR during the forecast period, owing to their efficacy in pain alleviation and widespread usage in companion animal postoperative pain management.

Injectable drugs are anticipated to witness the fastest revenue CAGR during the forecast period, owing to their high efficacy and immediate pain relief properties. Typically administered by veterinarians, injectables ensure precise dosing and administration for effective pain management in companion animals.

Regional Outlook: North America emerged as the dominant regional market in 2022, attributing its leading revenue share to increasing companion animal adoption rates and rising expenditure on pet healthcare. The region experienced a surge in pet ownership, particularly in the United States, coupled with a heightened frequency of postoperative pain cases among companion animals undergoing surgeries such as spaying and neutering.

Europe is poised to command a significantly large revenue share during the forecast period, propelled by a rising number of companion animal adoptions, notably dogs. With millions of pet dogs and cats in Europe, escalating expenditure on pet healthcare and the adoption of advanced therapeutics like NSAIDs and opioids are anticipated to drive market growth.

Asia Pacific is forecasted to witness the fastest revenue CAGR, driven by escalating companion animal adoption and increasing pet healthcare spending in countries like China and India. Notably, China's pet population exceeded 99 million in 2019, with substantial market size for pet products and services, indicative of the region's burgeoning pet industry. Rising awareness regarding postoperative pain management in companion animals further augments market growth prospects in the region.

Competitive Landscape: The global market for companion animal postoperative pain management therapeutics is characterized by a consolidated landscape, with a few major players commanding significant market share. Key market players include Zoetis Inc., Merck & Co., Inc., Elanco Animal Health Incorporated, Boehringer Ingelheim International GmbH, Bayer AG, Dechra Pharmaceuticals PLC, Norbrook Laboratories Limited, Ceva Sante Animale S.A., Vetoquinol S.A., Virbac S.A., and Aratana Therapeutics Inc.

Explore Trending Reports:

Pressure Sensitive Adhesives Market-https://www.reportsanddata.com/report-detail/pressure-sensitive-adhesive-market

Construction Adhesive Market-https://www.reportsanddata.com/report-detail/construction-adhesive-market

Basalt Fiber Market-https://www.reportsanddata.com/report-detail/basalt-fiber-market

Ammonium Nitrate Market-https://www.reportsanddata.com/report-detail/ammonium-nitrate-market

Roofing Systems Market-https://www.reportsanddata.com/report-detail/roofing-systems-market

Polyimide Films Market-https://www.reportsanddata.com/report-detail/polyimide-film-market

Plastic Fasteners Market-https://www.reportsanddata.com/report-detail/plastic-fasteners-market

Request a customization of the report: https://www.reportsanddata.com/request-customization-form/6341

Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.

About Reports and Data    

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W

(Head of Business Development)

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com

Blogs | Press Release | Industry News | Our competencies

Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports

Browse More Latest Reports @ https://www.reportsanddata.com/report

Browse Latest Blogs: https://www.reportsanddata.com/blogs

Browse Latest Press Release: https://www.reportsanddata.com/press-release

Comments

Post a Comment

Popular posts from this blog

Aprotic Solvents Market Analysis by Size, Share, Growth, Trends, 2028

Market Overview: In 2020, the global market for aprotic solvents experienced significant revenue growth and is projected to maintain a double-digit revenue compound annual growth rate (CAGR) throughout the forecast period. Key drivers of this growth include the unique characteristics of aprotic solvents, such as high polarity, dipole moment, dielectric constant, low skin penetration, and stability in acidic conditions. Additionally, the rising utilization of aprotic solvents in various industries, including agriculture, pharmaceuticals, and electronics, both as reaction solvents and cleaning agents, is expected to further propel market revenue growth. Among the application segments, the oil & gas industry is anticipated to exhibit the highest revenue CAGR, followed by the pharmaceutical segment. Particularly, the continued use of N-Methyl-2-pyrrolidone solvent for various applications in the oil and gas sector is poised to drive market expansion. Get a sample copy of the Aproti...
Read more

Stroke Treatment Market Emerging Trends, Demand, Growth by Key Players and Forecast 2028

Market Overview: The global market for stroke treatment demonstrated significant strength in 2020 and is anticipated to experience a rapidly increasing revenue compound annual growth rate (CAGR) throughout the forecast period. The rise in the prevalence of chronic illnesses among the growing geriatric population is expected to drive the growth of market revenue. Additionally, the vulnerability of older individuals to strokes, coupled with the escalating consumption of tobacco and the increasing incidence of diabetes, is poised to further boost market growth in the near future. Companies Profiled in the Report: Key companies in the global market include Sanofi, Daiichi Sankyo Company, Limited., Johnson & Johnson Services, Inc., Amgen Inc., Boehringer Ingelheim GmbH, AstraZeneca, F. Hoffmann-La Roche (Genentech), Bristol-Myers Squibb Company, and Biogen Inc. These key players are investing significantly in technological advancements, production capacity, and strategic alliances su...
Read more